Despite significant advances in understanding the role of the TGF-β pathway in obesity, obesity-induced diseases, and cancer, critical questions remain about whether this pathway functions predominantly as a driver or suppressor in these conditions. This evidence concerns the gene TGFB1 and obesity disorder.